These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 14981108)
1. p53 and RB: simple interesting correlates or tumor markers of critical predictive nature? Cordon-Cardo C J Clin Oncol; 2004 Mar; 22(6):975-7. PubMed ID: 14981108 [No Abstract] [Full Text] [Related]
2. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Tzai TS; Tsai YS; Chow NH Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma. Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615 [TBL] [Abstract][Full Text] [Related]
4. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Singh A; Jones RF; Friedman H; Hathir S; Soos G; Zabo A; Haas GP Anticancer Res; 1999; 19(6B):5415-7. PubMed ID: 10697570 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300 [TBL] [Abstract][Full Text] [Related]
6. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer]. Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587 [TBL] [Abstract][Full Text] [Related]
7. Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts. Aprikian AG; Sarkis AS; Reuter VE; Cordon-Cardo C; Sheinfeld J Semin Urol; 1993 Aug; 11(3):137-44. PubMed ID: 8210835 [No Abstract] [Full Text] [Related]
8. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53. Landolfi JA; Terio KA Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444 [TBL] [Abstract][Full Text] [Related]
9. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index. Wright C; Thomas D; Mellon K; Neal DE; Horne CH Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321 [TBL] [Abstract][Full Text] [Related]
10. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification. Kalantari MR; Ahmadnia H Urol J; 2007; 4(4):230-3. PubMed ID: 18270948 [TBL] [Abstract][Full Text] [Related]
11. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222 [TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder. Dekairelle AF; Tombal B; Cosyns JP; Gala JL Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567 [TBL] [Abstract][Full Text] [Related]
14. Expression of lung resistance-related protein in transitional cell carcinoma of bladder. Zhu Y; Kong C; Zeng Y; Sun Z; Gao H Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883 [TBL] [Abstract][Full Text] [Related]
15. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749 [TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder. Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954 [TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway. Zhang G; Chen F; Cao Y; See WA Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019 [TBL] [Abstract][Full Text] [Related]
18. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder. Mahnken A; Kausch I; Feller AC; Krüger S Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373 [TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. Dalbagni G; Parekh DJ; Ben-Porat L; Potenzoni M; Herr HW; Reuter VE BJU Int; 2007 Feb; 99(2):281-5. PubMed ID: 17155984 [TBL] [Abstract][Full Text] [Related]
20. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH; Peh SC; Poppema S Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]